C Ohrt

Summary

Publications

  1. ncbi Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia
    W R Taylor
    U S Naval Medical Research Unit Number 2, Jakarta, Indonesia
    Clin Infect Dis 28:74-81. 1999
  2. ncbi Referral times of Vietnamese refugees with tuberculosis in camps in Hong Kong
    W R Taylor
    The British Red Cross Society, Hong Kong
    Int J Tuberc Lung Dis 4:350-5. 2000
  3. ncbi Chloroquine/doxycycline combination versus chloroquine alone, and doxycycline alone for the treatment of Plasmodium falciparum and Plasmodium vivax malaria in northeastern Irian Jaya, Indonesia
    W R Taylor
    United States Naval Medical Research Unit Number 2, Jakarta, Indonesia
    Am J Trop Med Hyg 64:223-8. 2001

Collaborators

Detail Information

Publications3

  1. ncbi Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia
    W R Taylor
    U S Naval Medical Research Unit Number 2, Jakarta, Indonesia
    Clin Infect Dis 28:74-81. 1999
    ..Corresponding figures for doxycycline were 96.3% (95% CI, 85.4-99.6) and 98% (95% CI, 88.0-99.9), respectively. Daily azithromycin offered excellent protection against P. vivax malaria but modest protection against P. falciparum malaria...
  2. ncbi Referral times of Vietnamese refugees with tuberculosis in camps in Hong Kong
    W R Taylor
    The British Red Cross Society, Hong Kong
    Int J Tuberc Lung Dis 4:350-5. 2000
    ..Two closed camps in Hong Kong for Vietnamese refugees...
  3. ncbi Chloroquine/doxycycline combination versus chloroquine alone, and doxycycline alone for the treatment of Plasmodium falciparum and Plasmodium vivax malaria in northeastern Irian Jaya, Indonesia
    W R Taylor
    United States Naval Medical Research Unit Number 2, Jakarta, Indonesia
    Am J Trop Med Hyg 64:223-8. 2001
    ..vivax. These findings support the use of chloroquine/doxycycline as an inexpensive alternative to mefloquine for treating chloroquine-resistant P. falciparum but not chloroquine-resistant P. vivax in this setting...